FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly represents a method of treating and/or preventing overweight and/or obesity related disorders, including diabetes mellitus. Implementing the method according to the invention implies prescribing a composition containing sibutramine and microcrystalline cellulose to a patient.
EFFECT: method of treating and/or preventing overweight and/or obesity related disorders according to the invention provides the high clinical effectiveness with reducing side effects.
2 cl, 3 dwg, 8 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION AND KIT FOR TREATING AND/OR PREVENTING OBESITY-RELATED DISORDERS, AND METHOD OF TREATING AND/OR PREVENTING OBESITY-RELATED DISORDERS | 2013 |
|
RU2530628C1 |
| PHARMACEUTICAL COMBINATION FOR TREATING AND/OR PREVENTING DISORDERS RELATED TO OVERWEIGHT AND/OR OBESITY, AND BASED METHOD OF TREATING | 2014 |
|
RU2552926C1 |
| METHOD OF TREATING AND/OR PREVENTION OF EXCESSIVE BODY WEIGHT AND/OR OBESITY AND/OR METABOLIC DISORDERS | 2008 |
|
RU2403038C2 |
| METHOD OF TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS AND MEDICATION FOR TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS | 2010 |
|
RU2552221C2 |
| METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
| METHOD OF TREATING ESSENTIAL ARTERIAL HYPERTENSION AT BACKGROUND OF OBESITY | 2013 |
|
RU2563832C2 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME WITH DEPRESSIVE DISORDERS | 2013 |
|
RU2550724C1 |
| METHOD OF TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS | 2013 |
|
RU2582393C2 |
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES AND REPRODUCTIVE DISORDERS IN FEMALES AT AGE OF 18-35 YEARS OLD SUFFERING METABOLIC DISORDERS | 2013 |
|
RU2527358C1 |
